AI Article Synopsis
- A 56-year-old man with chronic hepatitis C and hepatocellular carcinoma (HCC) experienced tumor invasion of the right portal vein and underwent multiple treatments.
- He received intrahepatic artery infusion chemotherapy combined with interferon alpha, which reduced both the size of the HCC and portal tumor thrombus, successfully lowering the PIVKA-II levels with minimal side effects.
- In February 2001, further treatment involved laparoscopic devascularization and radiofrequency ablation (RFA) on the liver, resulting in normalized PIVKA-II levels, highlighting the importance of tailored interdisciplinary therapy for HCC management.
Article Abstract
A 56-year-old male patient with chronic C type hepatitis had HCC which invaded right portal vein trunk (Vp3). In August 2000, we performed intrahepatic artery infusion chemotherapy with CDDP and 5-FU under subcutaneous interferon alpha treatment. In addition, we used chemoradiation therapy for portal tumor thrombus in HCC. As the result of such therapy, the size of HCC and portal tumor thrombus reduced and the level of PIVKA-II decreased. There were no side effects except fever due to interferon alpha treatment. In February 2001, we performed devascularization and RFA therapy for HCC in S7 of liver under laparoscope. The level of PIVKA-II was within the normal range. It is important to perform interdisciplinary therapy appropriate for the HCC status.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!